The takeaway
Phibro Animal Health Corporation shows a slight seasonal lean over 10 years of data — strongest in June (+1.9%) and softest in March (−0.5%).
Right now
In July, the stock has fallen 50% of years, averaging −0.5%, roughly 2.6 pts behind the S&P 500.
The full picture
Phibro Animal Health Corporation's most dependable month has been June, higher in 8 of 10 years; March has been its least reliable, up just 30% of the time.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Win rate % | ||||||||||||
| Median return % | ||||||||||||
| 2025 | ||||||||||||
| 2024 | ||||||||||||
| 2023 | ||||||||||||
| 2022 | ||||||||||||
| 2021 | ||||||||||||
| 2020 | ||||||||||||
| 2019 | ||||||||||||
| 2018 | ||||||||||||
| 2017 | ||||||||||||
| 2016 |
Month by month
The stock's clearest edge over the S&P 500 lands in May (+3.8 pts); it has trailed the market most in November (−7.3 pts).
“vs S&P” is Phibro Animal Health Corporation’s average for a month minus the S&P 500’s average for that same month — isolating Phibro Animal Health Corporation’s own seasonal edge from broad market drift.
Reality check
Over the last 5 years, June has closed higher 80% of the time versus 80% across the last 10 years — the pattern is holding.
Figures are the typical (median) June return and how often it rose — the last 5 years versus the last 10(the heatmap’s default window). This verdict stays anchored to that 10-year window even if you zoom the chart, so it never disagrees with the badges above.
In plain English
The seasonal story is really one month's story — June. It has closed higher in 8 of 10 Junes, a concentration the rest of the calendar can't touch.
The strength looks broad-based rather than freakish: its average (+1.9%) and median (+2.4%) sit close together, so no single blow-out year is flattering the figure. No month is steadier: June's returns vary by just 4.2% year to year, and even its worst June in 10 years lost only 5.8% — the gentlest downside anywhere on its calendar. Better still, that strength is the stock's own and not just a buoyant market — June has outpaced the S&P 500 by +1.7 points on average. Few peers keep such company in June — the typical stock clears it just 52% of the time.
June anchors a run, too: the April-through-June window has been the stock's reliable season. The weaker half of the year is plainer: March has been the soft spot — the weakest of 4 months that average a loss (−0.5%), and the edge isn't year-round — the stock has trailed the S&P 500 in November, July, and September. Its roughest month on record was a −34.4% August in 2019 — a reminder of how hard even a seasonal name can fall.
At its steadiest, June strung together 7 straight positive years. Reassuringly, the tendency has held its shape: the recent five years still track the years behind them.
For a stock this dependable in June, the sharper question is the rest of the year — outside its strong stretch, the calendar gives far less to lean on.
Short answers on the stock's best month (June), its worst (March), and whether it really trades seasonally.
Only mildly. The stock's months are fairly even — June is the firmest (+1.9%) and March the softest (−0.5%), a narrow spread that points to weak seasonality rather than a strong calendar effect.
June has been the strongest, averaging +1.9% and closing higher in 8 of 10 years since 2016.
It's the weakest, averaging −0.5% — historically a soft spot, though it still varies from year to year.
Explore
These names have the strongest July track records on record — a starting point for comparison.
Before you trade